Previous Next

Welcome to the UCLA Department of Medicine Office of Equity, Diversity and Inclusion

The mission of DOM EDI is to become the exemplar Department of Medicine program/center in the nation for advancing diversity, equity and inclusion for students, residents, fellows and faculty in the context of scientific excellence, outstanding scholarship/innovation and the highest level of compassionate, high-quality care for our patients. To do this, we focus our efforts on open conversation, sharing ideas, data, and knowledge to build a thriving and inclusive community that fosters the success of us all. 

Together we are stronger. Together we are better.

Our Team

Keith C. Norris, MD, PhD 
Executive Vice Chair, Department of Medicine for Equity, Diversity, and Inclusion
Professor of Medicine, UCLA Division of General Internal Medicine and Health Services Research.

 

Teresa Seeman, PhD
Associate Vice Chair, Department of Medicine for Equity, Diversity, and Inclusion
Professor of Medicine & Epidemiology, UCLA Geffen School of Medicine

 

Marco Hidalgo, PhD
Associate Vice Chair, Department of Medicine Office for Equity, Diversity, and Inclusion
Associate Clinical Professor of Medicine, Division of Internal Medicine and Health Services Research, Medicine-Pediatrics Section

 

Utibe Essien, MD, MPH
Associate Vice Chair, Department of Medicine Office for Equity, Diversity, and Inclusion
Assistant Professor of Medicine in Residence at the David Geffen School of Medicine at UCLA

 

Alejandra Casillas, MD, MSHS
Founder of the First-Generation Program at DGSOM
Assistant Professor of Medicine in Residence at the David Geffen School of Medicine at UCLA

 

Cristina Punzalan, MPH
Program Manager 
Department of Medicine for Equity, Diversity, and Inclusion
RCMAR CHIME

 

Anais Gascon
Program Coordinator 
Department of Medicine for Equity, Diversity, and Inclusion
RCMAR CHIME

Highlights

Our People, Our Patients, Our Community: Guiding UCLA Health's Journey to Achieve Health Equity and Justice

Pursuing Pharmacoequity: Race and Novel Drugs in the U.S.

Affirmative Action and Equity in Academia: To Be or Not To Be

Read the Q+A here